We are live on ! Find out more
MWVC

Morgens Waterfall Vintiadis & Co Portfolio holdings

AUM $81.2M
1-Year Est. Return 86.87%
This Fund
S&P 500
This Quarter Est. Return
+16.73%
1 Year Est. Return
+86.87%
3 Year Est. Return
+484.3%
5 Year Est. Return
+875.12%
10 Year Est. Return
+12,893.79%
AUM
$141M
AUM Growth
+$9.62M
Cap. Flow
-$5.53M
Cap. Flow %
-3.92%
Top 10 Hldgs %
45.35%
Holding
70
New
16
Increased
11
Reduced
12
Closed
16

Top Buys

Rank Stock Value
1
OKTA icon
Okta
OKTA
+$4.05M
2
EL icon
Estee Lauder
EL
+$3.9M
3
APTI
Apptio, Inc. Class A Common Stock
APTI
+$3.34M
4
VRNS icon
Varonis Systems
VRNS
+$3.06M
5
BBWI icon
Bath & Body Works
BBWI
+$2.93M

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$5.12M
2
WYNN icon
Wynn Resorts
WYNN
+$5M
3
MRVL icon
Marvell Technology
MRVL
+$4.37M
4
TTWO icon
Take-Two Interactive
TTWO
+$3.46M
5
SHOP icon
Shopify
SHOP
+$3.42M

Sector Composition

Rank Sector Weight
1 Technology 31.65%
2 Consumer Discretionary 21.84%
3 Healthcare 13.09%
4 Communication Services 12.15%
5 Industrials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMS
26
DELISTED
Adamas Pharmaceuticals
ADMS
$1.79M 1.27%
69,500
+32,500
+88% +$900K
ADMA icon
27
ADMA Biologics
ADMA
$1.96B
$1.69M 1.2%
375,000
+75,000
+25% +$374K
HRTX icon
28
Heron Therapeutics
HRTX
$93.9M
$1.51M 1.07%
+39,000
New +$1.24M
AAPL icon
29
Apple
AAPL
$4.54T
$1.47M 1.04%
31,752
+18,000
+131% +$816K
V icon
30
Visa
V
$684B
$1.4M 0.99%
10,594
-1,500
-12% -$193K
RETA
31
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.4M 0.99%
+40,000
New +$1.22M
ILMN icon
32
Illumina
ILMN
$31B
$1.4M 0.99%
5,140
– –
MA icon
33
Mastercard
MA
$506B
$1.28M 0.9%
6,500
– –
MDSO
34
DELISTED
Medidata Solutions, Inc.
MDSO
$1.24M 0.88%
15,400
– –
EDIT icon
35
Editas Medicine
EDIT
$396M
$1.07M 0.76%
30,000
– –
BA icon
36
Boeing
BA
$171B
$805K 0.57%
+2,400
New +$826K
VRML
37
DELISTED
Vermillion, Inc.
VRML
$781K 0.55%
1,000,000
– –
TRHC
38
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$766K 0.54%
+12,000
New +$589K
KKR icon
39
KKR & Co
KKR
$91.1B
$746K 0.53%
+30,000
New +$667K
TXMD icon
40
TherapeuticsMD
TXMD
$23.5M
$699K 0.5%
2,240
– –
EHTH icon
41
eHealth
EHTH
$42.2M
$663K 0.47%
+30,000
New +$579K
CRSP icon
42
CRISPR Therapeutics
CRSP
$4.73B
$588K 0.42%
10,000
– –
BP icon
43
BP
BP
$116B
$572K 0.41%
13,315
-21,697
-62% -$912K
MMM icon
44
3M
MMM
$90.9B
$570K 0.4%
+3,468
New +$592K
RDS.B
45
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$566K 0.4%
7,792
-12,500
-62% -$900K
ZBRA icon
46
Zebra Technologies
ZBRA
$14B
$559K 0.4%
+3,900
New +$574K
CSX icon
47
CSX Corp
CSX
$93.4B
$542K 0.38%
+25,500
New +$525K
LNW
48
DELISTED
Light & Wonder
LNW
$541K 0.38%
+11,000
New +$581K
MGP
49
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$525K 0.37%
17,250
– –
HXL icon
50
Hexcel
HXL
$7.79B
$491K 0.35%
+7,400
New +$505K
1
2
3

Similar funds

RTC
Riverview Trust Company Vancouver, Washington $81.2M AUM 18.57% 1-Year Est. Return
SPW
Sonoma Private Wealth Sonoma, California $81.2M AUM 22.25% 1-Year Est. Return
MC
Medici Capital Newport Beach, California $81.2M AUM 76.04% 1-Year Est. Return
FPAM
Feynman Point Asset Management New York $81.1M AUM
BCM
Beaumont Capital Management Boston, Massachusetts $81M AUM 17.14% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
AGFVA
Accel Growth Fund V Associates Palo Alto, California $81.7M AUM 29.05% 1-Year Est. Return
HM
HCEP Management Hong Kong $80.7M AUM 1.24% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's Q2 2018 Portfolio in Review

As of Q2 2018, Morgens Waterfall Vintiadis & Co held 70 positions worth $141M, up 7.3% from $132M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Morgens Waterfall Vintiadis & Co withdrew a net $5.53M in Q2 2018, closing 16 positions and reducing 12 holdings. Its most notable exit was Salesforce, an estimated $5.12M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Morgens Waterfall Vintiadis & Co opened a new position in Okta worth $4.28M.

  • Morgens Waterfall Vintiadis & Co's largest Q2 2018 buy was Okta: 85,000 shares worth $4.28M.
  • Morgens Waterfall Vintiadis & Co added most to ON Semiconductor in Q2 2018, an estimated $967K increase.
  • Morgens Waterfall Vintiadis & Co's biggest Q2 2018 reduction was BP, cutting an estimated $912K.
  • Morgens Waterfall Vintiadis & Co fully exited Salesforce in Q2 2018, selling an estimated $5.12M.
  • Morgens Waterfall Vintiadis & Co's ten largest holdings make up 45% of its $141M portfolio in Q2 2018.
  • Morgens Waterfall Vintiadis & Co opened 16 new positions and closed 16 in Q2 2018.
  • Morgens Waterfall Vintiadis & Co's portfolio value rose 7.3% quarter-over-quarter to $141M.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q2 2018, filed 14 Aug 2018.